Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bio's Q4 Revenues Rise 22 Percent as R&D Swells and Losses Narrow

NEW YORK (GenomeWeb News) — Harvard Bioscience yesterday said fourth-quarter revenue rose 22 percent as R&D spending increased 17 percent, and losses narrowed by 75 percent.
Total receipts for the three months ended Dec. 30, 2006, increased to $21.7 million from $17.8 million year over year.
 
The company said revenue grew “across various product lines,” but was mainly due to greater demand for physiology and cell-biology equipment, “particularly in Asia Pacific and in Europe.”
 
Also contributing to the rise were sales from the plate reader product line it obtained when it acquired washer products from Anthos Labtecin last June.
 
R&D spending increased to $820,000 from $700,000 in the year-ago period. 

Harvard Bio reported $2.4 million in net losses in the quarter compared to a loss of $9 million during the same period last year.

 
The company said residual losses came from the 2005 divestiture of its Capital Equipment Business. As a discontinued operation, that unit cost Harvard Bio $4.3 million in the fourth quarter of 2006, compared with $11.3 million in the year-ago period. 
 
The company said it had around $9.4 million in cash and equivalents as of Dec. 31.
 
Looking forward, Harvard Bioscience projected revenues between $18.5 million and $19.5 million.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.